Online citations, reference lists, and bibliographies.
← Back to Search

HYPERTENSIVE CRISIS DUE TO MONOAMINE-OXIDASE INHIBITORS.

B. Blackwell
Published 1963 · Medicine

Cite This
Download PDF
Analyze on Scholarcy
Share
This paper references



This paper is referenced by
10.1177/026988118900300107
Potentiation of the pressor effect of oral and intravenous tyramine during administration of the selective MAO-A inhibitor moclobemide in healthy volunteers
S. Wijnands (1989)
10.1111/j.1476-5381.1989.tb12625.x
The influence of amine metabolizing enzymes on the pharmacology of tyramine in the isolated perfused mesenteric arterial bed of the rat
J. Elliott (1989)
10.1038/clpt.1983.228
Oral absorption and concentration‐effect relationship of tyramine with and without cimoxatone, a type‐A specific inhibitor of monoamine oxidase
C. Dollery (1983)
10.3136/NSKKK.53.337
イシル(魚醤油)中のポリアミン含量について
俊英 道畠 (2006)
Irreversible Monoamine Oxidase Inhibitors Revisited
Kenneth J. Bender (2012)
10.1136/jnnp.41.10.930
Coital cephalgia and ischaemic muscular work of the lower limbs.
H. Staunton (1978)
10.1097/AJP.0b013e31819a6f65
Foods and Supplements in the Management of Migraine Headaches
C. Sun-Edelstein (2009)
10.1038/bjp.2008.286
Dietary trace amine‐dependent vasoconstriction in porcine coronary artery
A. A. Herbert (2008)
10.1111/J.1749-6632.1965.TB12243.X
DRUG TOXICITY AS A RESULT OF INTERFERENCE WITH PHYSIOLOGICAL CONTROL MECHANISMS.
J. Gillette (1965)
10.1001/ARCHOPHT.1965.00970030508011
THE HISTOPATHOLOGY OF EARLY CENTRAL RETINAL ARTERY OCCLUSION.
B. E. Dahrling (1965)
10.1177/070674378402900814
Diet and Monoamine Oxidase Inhibitors: A Re-Examination
E. Sullivan (1984)
10.1007/978-3-211-33328-0_9
The relationship of early studies of monoamine oxidase to present concepts.
I. Kopin (2006)
Selegilinetransdermalsystem: anoveltreatmentoptionfor majordepressivedisorder
Jayasree J. Nandagopal (2009)
10.1177/003693306400900607
Undesirable Drug Combinations
J. Moore (1964)
10.5772/18654
The Knoll-Concept to Decrease the Prevalence of Parkinson’s Disease
I. Miklya (2011)
10.1017/9781911623465.003
A Brief History of Psychopharmacology
P. Haddad (2020)
10.1007/BF03004695
Malignant hyperthermia: Aetiology unknown
B. A. Brut (1970)
10.1126/SCIENCE.6424235
Isolated chromaffin cells from adrenal medulla contain primarily monoamine oxidase B.
M. B. Youdim (1984)
10.1002/MED.2610120504
Pharmacological basis of the therapeutic effect of (−)deprenyl in age‐related neurological diseases
J. Knoll (1992)
10.1136/dtb.1994.3216
▼Moclobemide for depression
J. Tiller (1994)
10.1016/S0025-7125(05)70113-9
Monoamine oxidase and catechol-O-methyltransferase inhibitors.
A. Siderowf (1999)
10.1179/016164105X25216
Pathophysiology of an hypoxic–ischemic insult during the perinatal period
J. Calvert (2005)
10.1002/JBM.820010408
Toxicologic aspects of implants.
J. Autian (1967)
10.1111/J.1476-5381.1968.TB00990.X
The mechanism of the augmentation of responses to indirectly acting sympathomimetic amines by monoamine oxidase inhibitors.
M. Rand (1968)
10.1007/BF01406771
Bericht über eine intrazerebrale Blutung nach längerer Behandlung mit einem Monoaminooxydase-(MAO-)Hemmer
F. Römer (2005)
10.1002/JPS.2600610602
Monoamine oxidase inhibitors.
B. Ho (1972)
10.2165/00003495-198121040-00003
Adverse Effects of Antidepressant Drugs
B. Blackwell (2012)
[Occurrence of biogenic amines in ripening cheeses taken from the Warsaw market].
D. Sawilska-Rautenstrauch (2010)
10.1097/00131746-200407000-00005
The Role of Monoamine Oxidase Inhibitors in Current Psychiatric Practice
J. Fiedorowicz (2004)
DRUG-DRUG INTERACTIONS - FROM KNOWLEDGE BASE TO CLINICAL IMPACT
Marine L. Andersson (2014)
10.1016/S0140-6736(66)91399-7
POTENTIATION OF INSULIN HYPOGLYCÆMIA BY M.A.0.1. ANTIDEPRESSANT DRUGS
A. Cooper (1966)
10.1111/J.1600-0773.1998.TB01399.X
(-)Deprenyl (selegiline), a catecholaminergic activity enhancer (CAE) substance acting in the brain.
J. Knoll (1998)
See more
Semantic Scholar Logo Some data provided by SemanticScholar